Corpay, Inc.: JPMorgan raises target price to $500 from $470
CPAY•JPMorgan raised its target price for Corpay to $500 from $470.
Related News
AstraZeneca rises after it reportedly made $10 billion bid for obesity drugmaker Rhythm
AZN•
TD Cowen raises Revolution Medicines target price to $270 from $250
RVMD•
Evotec 9M 2026 operating loss more than doubles to EUR 254.78 million
EVO•
Before the bell: rotation out of AI rolls on ahead of BoE
SPY•
United Therapeutics: Raymond James raises target price to $720 from $717
UTHR•